Sesen Bio Inc (SESN)

[whytestocks]

News: $SESN Sesen Bio Announces Acceptance of Analytical Comparability Plan by the U.S. Food and Drug Administration to Support the BLA and Commercialization of Its Lead Asset, Vicinium® for Non-Muscle Invasive Bladder Cancer

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that the Company has completed its Type C CMC meeting and has reached agreement with the U.S. Food and Drug Administration (FDA...

Read the whole news https://marketwirenews.com/news-releases/sesen-bio-announces-acceptance-of-analytical-comparability-plan-by-the-u-s-food-and-drug-administration-to-support-the-bla-and-commercialization-of-its-lead-asset-vicinium-xae-for-non-muscle-invasive-bladder-cancer-8221160.html